Everett Moding, MD, PhD
@everettmoding
#PhysicianScientist @StanfordRadOnc studying #radiationbiology and #cancerevolution using #ctDNA and #GEMMs
ID: 224736927
http://modinglab.stanford.edu 09-12-2010 18:59:38
306 Tweet
730 Takipçi
758 Takip Edilen
SCI member Everett Moding & others define the landscape of diverse malignant and stromal cell states within #SoftTissueSarcoma & patient response to #immuotherapy. go.nature.com/3TkzYtg Everett Moding, MD, PhD
I'm seeking a computational postdoc for my team Stanford Radiation Oncology! We're building ML tools to crack genomic data for enhancing early cancer detection (and more). Join us!🧬💻 Please RT! postdocs.stanford.edu/prospective/op…
🎉We are thrilled to announce our incredible #MATCH2024 doctors! So lucky to welcome you into our Stanford Radiation Oncology family! Allison Zhong, MD UC San Diego School of Medicine Nicholas Verdini, MD Tufts School of Medicine Jennifer Matsui The Ohio State University College of Medicine erroncollins Morehouse College Morehouse School of Medicine #MATCHDAY Stanford Radiation Oncology Residents
Honored to have the opportunity to edit the recent issue in Seminars in #RadOnc on the Role of Radiation Therapy in Sarcomas: sciencedirect.com/science/articl… Akila Viswanathan MD
Congrats Dr. Agnes Ewongwo, MD MPH and Dr. Hui! We reviewed the current state of molecular biomarkers in #sarcoma care. So much potential for #liquidbiopsy to personalize treatment, but work is necessary to improve sensitivity and demonstrate clinical utility! authors.elsevier.com/a/1inIG3lXQoUO…
Monumental effort by GLOW team in publishing the largest analysis of NLPHL to date and answering many key questions about age specific risks, the prognostic impact of variant patterns, and developing a new LP-IPS: ascopubs.org/doi/10.1200/JC… GLOW: Global nLPHL One Working Group Journal of Clinical Oncology Jamie Flerlage
Thank you kristac and Stanford Medicine for highlighting our recent work in Nature Cancer investigating the soft tissue #sarcoma microenvironment! med.stanford.edu/news/all-news/…
The registrational enabling Spearhead-1 study shows that afami-cel, an engineered T cell targeting MAGEA4, has promising efficacy in synovial sarcoma and MRCLS paving the way for T cell therapy in solid tumors. Memorial Sloan Kettering Cancer Center MSK Department of Medicine Sarcoma Service at Memorial Sloan Kettering sciencedirect.com/science/articl…
Using machine learning SCI member Everett Moding, MD, PhD & team found 3 cellular patterns in #SoftTissueSarcoma, linking them to patient outcomes and treatment response. bit.ly/3J7crpz
Our new paper "Proteomic features of soft tissue sarcomas in adolescents and young adults (AYA)" is out in Communications Medicine! nature.com/articles/s4385… We analyse the proteomic profiles of AYA #sarcomas and compared them with those from older patients. What did we find out? A 🧵1/6
It was a privilege to lead SU2C-SARC032 and present results at #ASCO2024. The trial was the result of the work of so many including Richard Riedel Yvonne Mowery Angela Hong & many other investigators
1/n 🚨 🧬Our paper on the role of #mitochondria and free radicals in promoting the collapse of #Cancer #micronuclei is out in Science Magazine today. A story led by the brilliant Melody Di Bona it started with a simple question: why do micronuclei rupture? science.org/doi/10.1126/sc…
I’m delighted to share our lab’s latest study now published Nature Genetics👉 tinyurl.com/2p97xpj8. Led by the fantastic duo Carina Shiau #JingyiCao, and a big collaborative effort with Martin Hemberg David Ting NanoString and others. 🧵
Great to see this work led by Justin Jagodinsky published! A product of team science and collaboration. UW Department of Human Oncology UW School of Medicine and Public Health Intratumoral radiation dose heterogeneity augments antitumor immunity in mice and primes responses to checkpoint blockade science.org/doi/abs/10.112…
